Security key
18978H508
CNS Pharmaceuticals, Inc. - Common Stock (CNSP)
CUSIP: 18978H508
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 1,614,040
- Total 13F shares
- 145,596
- Share change
- +21,359
- Total reported value
- $348,663
- Price per share
- $2.39
- Number of holders
- 11
- Value change
- +$7,140
- Number of buys
- 6
- Number of sells
- 2
Report period
Q1 2026
Institutions
11
Top holders
10
CNSP full security history
Previous quarter: Q4 2025
CNS Pharmaceuticals, Inc. SEC filings
CNS Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 18978H508
Recent filing periods:
Top shareholders of CNSP - CNS Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC |
13D/G
13F
|
Company |
9.9%
|
159,790
|
$402,671 | +$279,627 | 31 Mar 2026 | |
| Ikarian Capital, LLC |
13F
13D/G
|
Company |
5.7%
from 13D/G
|
45,830
|
$240,608 | — | 31 Dec 2025 | |
| ARMISTICE CAPITAL, LLC |
13D/G
|
— |
5%
|
30,177
|
$5,432 | -$95,575 | 30 Sep 2025 | |
| DRW Securities, LLC |
13F
|
Company |
0.96%
|
15,429
|
$81,002 | — | 31 Dec 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.84%
|
13,524
|
$71,001 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
611
|
$3,208 | — | 31 Dec 2025 | |
| BARRETT & COMPANY, INC. |
13F
|
Company |
0%
|
8
|
$42 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
4
|
$21 | — | 31 Dec 2025 | |
| MAI Capital Management |
13F
|
Company |
0%
|
3
|
$16 | — | 31 Dec 2025 | |
| DANSKE BANK A/S |
13F
|
Company |
0%
|
1
|
$5 | — | 31 Dec 2025 | |
| Waldemar Priebe |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
156,807
|
$198,486 | — | 06 Dec 2022 | |
| Cortice Biosciences, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
573,368
|
$172,010 | — | 30 Jul 2024 | |
| Carl Anthony Evans |
3/4/5
|
Director |
—
mixed-class rows
|
501,001
mixed-class rows
|
$54,165 | — | 08 Apr 2024 | |
| Sound Income Strategies, LLC |
13F
|
Company |
—
class O/S missing
|
16
|
$113 | — | 31 Dec 2025 | |
| Andrzej Andraczke |
3/4/5
|
Director |
—
class O/S missing
|
45,428
|
— | — | 21 Sep 2023 | |
| Rami Levin |
3/4/5
|
CEO and President, Director |
—
class O/S missing
|
19,000
|
— | — | 01 Jan 2026 | |
| John M. Climaco |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
9,761
|
— | — | 17 Nov 2025 | |
| Eric Faulkner |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
9,500
|
— | — | 02 Mar 2026 | |
| Steve O'Loughlin |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
9,500
|
— | — | 02 Mar 2026 | |
| Christopher Downs |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
4,881
|
— | — | 17 Nov 2025 | |
| Amy Mahery |
3/4/5
|
Director |
—
class O/S missing
|
1,517
|
— | — | 17 Nov 2025 | |
| Bettina M. Cockroft |
3/4/5
|
Director |
—
class O/S missing
|
1,517
|
— | — | 17 Nov 2025 | |
| Jeffry R. Keyes |
3/4/5
|
Director |
—
class O/S missing
|
1,517
|
— | — | 17 Nov 2025 | |
| Jerzy Gumulka |
3/4/5
|
Director |
—
class O/S missing
|
1,517
|
— | — | 17 Nov 2025 |
Institutional Holders of CNS Pharmaceuticals, Inc. - Common Stock (CNSP) as of Q1 2026
As of 31 Mar 2026,
CNS Pharmaceuticals, Inc. - Common Stock (CNSP) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
145,596 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, Tower Research Capital LLC (TRC), UBS Group AG, BARRETT & COMPANY, INC., MAI Capital Management, CITIGROUP INC, and Caitong International Asset Management Co., Ltd.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
9
Q1 2026 holders
11
Holder diff
2
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.